- Home
- HUMA vs SOR Comparison
HUMA vs SOR Comparison
Compare HUMA & SOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMA
- SOR
- Stock Information
- Founded
- HUMA 2004
- SOR 1968
- Country
- HUMA United States
- SOR United States
- Employees
- HUMA N/A
- SOR N/A
- Industry
- HUMA Biotechnology: Pharmaceutical Preparations
- SOR Investment Managers
- Sector
- HUMA Health Care
- SOR Finance
- Exchange
- HUMA Nasdaq
- SOR Nasdaq
- Market Cap
- HUMA 250.2M
- SOR 364.9M
- IPO Year
- HUMA N/A
- SOR N/A
- Fundamental
- Price
- HUMA $1.51
- SOR $44.50
- Analyst Decision
- HUMA Strong Buy
- SOR
- Analyst Count
- HUMA 8
- SOR 0
- Target Price
- HUMA $10.88
- SOR N/A
- AVG Volume (30 Days)
- HUMA 5.9M
- SOR 16.2K
- Earning Date
- HUMA 08-11-2025
- SOR 01-01-0001
- Dividend Yield
- HUMA N/A
- SOR 7.24%
- EPS Growth
- HUMA N/A
- SOR N/A
- EPS
- HUMA N/A
- SOR 6.50
- Revenue
- HUMA $818,000.00
- SOR N/A
- Revenue This Year
- HUMA N/A
- SOR N/A
- Revenue Next Year
- HUMA $949.92
- SOR N/A
- P/E Ratio
- HUMA N/A
- SOR $6.41
- Revenue Growth
- HUMA N/A
- SOR N/A
- 52 Week Low
- HUMA $1.15
- SOR $36.41
- 52 Week High
- HUMA $6.77
- SOR $42.75
- Technical
- Relative Strength Index (RSI)
- HUMA 36.87
- SOR 63.93
- Support Level
- HUMA $1.43
- SOR $43.65
- Resistance Level
- HUMA $1.67
- SOR $44.86
- Average True Range (ATR)
- HUMA 0.15
- SOR 0.63
- MACD
- HUMA -0.01
- SOR 0.05
- Stochastic Oscillator
- HUMA 23.32
- SOR 68.46
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
About SOR Source Capital Inc.
Source Capital Inc is a diversified, closed-end management investment company. The investment objective of the company is to seek maximum total return for Common shareholders from both capital appreciation and investment income to the extent consistent with the protection of invested capital.